Investigating novel KRAS inhibitors effects on the tumor-immune responses and integration of KRAS inhibition with immune based therapies. Grant uri icon

Overview

date/time interval

  • October 1, 2023 - September 30, 2024

sponsor award ID

  • MFCR 227111-01

Affiliation